VOMTO Antivertigo & Vestibular Antiemetic
Trusted relief. Restored comfort.

Franchise & Quality Guarantee
VOMTO
LASTING RELIEF FROM NAUSEA, DIZZINESS & VERTIGO.
“Trusted relief. Restored comfort.”
Formulation Overview
VOMTO provides sustained-release Meclizine Hydrochloride, an H1-receptor antagonist with central anticholinergic and CNS depressant properties. Specially designed to suppress vestibular end-organ receptors, effectively mitigating vertigo, dizziness, and motion-induced nausea.
Active Pharmaceutical Ingredients (APIs)Each Unit Contains
| Ingredient Name | Dosage / Strength |
|---|---|
| Meclizine HCL (SR) | 50mg |
Therapeutic Indications & Clinical Use
Key Formulation Advantages
As directed by the Physician.
Store in a cool, dry and dark place. Protect from direct heat.
Distribute VOMTO in Your Territory
Secure exclusive district monopoly marketing rights for VOMTO (Tablet). We provide attractive distributor profit margins, digital promotional flyers, and prompt dispatch from Ahmedabad, Gujarat across 15+ states.
Direct communication with Vikson Lifescience PCD Franchise Management Team, Gheekanta, Ahmedabad.
More Formulations in Tablets
Complete support. Comfort through every trimester.


